Proter S.P.A.
Records under this name other than the patents Proter S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 4,216,208 | N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity Term ended Term ended no later than Aug 5, 2000 · Low confidence | Term ended | Term ended no later than Aug 5, 2000 | Low confidence |
| US 4,244,968 | Treatment of arthritis and substances for use in such treatment Term ended Term ended no later than Jan 13, 2001 · Low confidence | Term ended | Term ended no later than Jan 13, 2001 | Low confidence |
| US 4,314,999 | N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity Term ended Term ended no later than Feb 9, 2002 · Low confidence | Term ended | Term ended no later than Feb 9, 2002 | Low confidence |
| US 4,428,875 | Compounds of dichlorodiethylaminophenylalanine with anti-tumor activity Term ended Term ended no later than Jan 31, 2004 · Low confidence | Term ended | Term ended no later than Jan 31, 2004 | Low confidence |
| US 4,485,248 | Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxyethoxy-benzyl)-pyrimidine Term ended Term ended no later than Nov 27, 2004 · Low confidence | Term ended | Term ended no later than Nov 27, 2004 | Low confidence |
| US 4,508,710 | In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound Formerly held Term ended Term ended no later than Apr 2, 2005 · Low confidence | Term ended | Term ended no later than Apr 2, 2005 | Low confidence |
| US 4,540,683 | In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound Term ended Term ended no later than Sep 10, 2005 · Low confidence | Term ended | Term ended no later than Sep 10, 2005 | Low confidence |
| US 4,666,887 | Intravenous or intraperitoneal administration of a tripeptide compound for treating cancer Term ended Term ended no later than May 19, 2007 · Low confidence | Term ended | Term ended no later than May 19, 2007 | Low confidence |
| US 4,740,501 | Interference of b-type retrovirus replication with a tripeptide compound Term ended Term ended no later than Apr 26, 2008 · Low confidence | Term ended | Term ended no later than Apr 26, 2008 | Low confidence |
| US 4,861,599 | Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use Formerly held Term ended Term ended no later than Aug 29, 2009 · Low confidence | Term ended | Term ended no later than Aug 29, 2009 | Low confidence |